Prestige Consumer Healthcare (PBH) EBIT Margin (2010 - 2025)

Prestige Consumer Healthcare has reported EBIT Margin for 16 years, with the latest figure at 29.1% in Q4 2025.

• On a quarterly basis, EBIT Margin fell 257.0% year-over-year to 29.1% in Q4 2025; TTM through Dec 2025 was 29.21%, a 35.0% decrease from a year earlier, with the FY2025 full-year figure at 29.6%, down 83.0% from the prior year.
• EBIT Margin was 29.1% for Q4 2025 at Prestige Consumer Healthcare, roughly flat from 29.06% in the prior quarter.
• The five-year high for EBIT Margin was 33.93% in Q2 2021, with the low at 98.3% in Q1 2023.
• Average EBIT Margin over 5 years is 23.6%, with a median of 29.77% recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: EBIT Margin plunged 12730 bps in 2023, then surged 12795 bps in 2024.
• Over 5 years, EBIT Margin stood at 30.09% in 2021, then grew by 5 bps to 31.64% in 2022, then retreated by 3 bps to 30.71% in 2023, then advanced by 3 bps to 31.68% in 2024, then dropped by 8 bps to 29.1% in 2025.
• The last three EBIT Margin figures came in at 29.1% (Q4 2025), 29.06% (Q3 2025), and 28.76% (Q2 2025), per Business Quant data.